You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ly3214996

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Cancer Metastatic, BRAF V600E Trial in Indianapolis (Abemaciclib, LY3214996)

Recruiting
  • Cancer
  • +6 more
  • Indianapolis, Indiana
    Indiana University Hospital / IU Simon Cancer Center
Jan 12, 2023

Acute Myeloid Leukemia Trial in Boston (LY3214996)

Recruiting
  • Acute Myeloid Leukemia
  • LY3214996
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jun 6, 2022

Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in Amsterdam (RMC-4630, LY3214996)

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • (no location specified)
Mar 9, 2022

Glioblastoma, GBM, Glioma Trial in Chandler, Phoenix, Scottsdale (Abemaciclib, LY3214996)

Recruiting
  • Glioblastoma
  • +2 more
  • Chandler, Arizona
  • +2 more
Mar 10, 2022

Pancreatic Cancer, Advanced Cancer Trial in Boston, Chapel Hill (Hydroxychloroquine Sulfate, LY3214996)

Recruiting
  • Pancreatic Cancer
  • Advanced Cancer
  • Hydroxychloroquine Sulfate
  • LY3214996
  • Boston, Massachusetts
  • +2 more
Apr 6, 2022

Advanced Cancer, Metastatic Melanoma, Metastatic NSCLC Trial in Worldwide (LY3214996, Midazolam, Abemaciclib)

Active, not recruiting
  • Advanced Cancer
  • +3 more
  • LY3214996
  • +6 more
  • Washington, District of Columbia
  • +12 more
Sep 2, 2021

Healthy Trial in Madison (LY3214996, [14C]-LY3214996)

Completed
  • Healthy
  • Madison, Wisconsin
    Covance Clinical Research Inc
Oct 26, 2019

Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Mantle Cell Lymphoma Trial (Ibrutinib, LY3214996)

Withdrawn
  • Chronic Lymphocytic Leukemia
  • +3 more
  • (no location specified)
Feb 3, 2020